INSEAD Day 4 - 728x90

Samsung biggest chip investor

The tech giant invested nearly $59.2bn in 2025.

flynas to set up new hub

Five destinations in first phase of operations.

AD Ports Group acquires CLI

CLI is Brazilian agri-bulk terminal operator.

$1.59bn Makkah project awarded

A consortium will develop two districts in the Holy City.

2PointZero posts profit surge

Growth driven by merger consolidation.

Riyadh clears Moderna vaccine for people aged between 12 and 17

  • Clinical studies and reports showed the vaccine's effectiveness and safety
  • The Moderna COVID-19 vaccine was registered in the Kingdom on July 9, 2021

Saudi Arabia has approved the use of the Moderna Covid-19 vaccine for people aged between 12 and 17.

According to state news agency SPA the decision of the authority was based on the data provided by the pharmaceutical company, which showed its vaccine had met special regulatory requirements, and included clinical studies and reports showing its effectiveness and safety.

SFDA’s review found that the known and potential benefits of the vaccine on individuals 12 years of age or older outweigh the risks.

The Moderna COVID-19 vaccine was registered in the Kingdom on July 9, 2021 for those aged 17 years and older.